Determinants of CD81 dimerization and interaction with hepatitis C virus glycoprotein E2

Biochemical and Biophysical Research Communications

Volumn 328, Issue 1, 2005, Pages 251-257

  Drummer, Heidi E ^a   Wilson, Kirilee A ^a   Poumbourios, Pantelis ^a  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

CD81; Glycoprotein E2; HCV receptor; Hepatitis C virus; Tetraspanin

Indexed keywords

AMINO ACID; BRIDGED COMPOUND; CD81 ANTIGEN; DIMER; DISULFIDE; EPITOPE; GLYCOPROTEIN E; GLYCOPROTEIN E2; MONOMER; MUTANT PROTEIN; RECOMBINANT ANTIGEN; SODIUM CHLORIDE; TETRASPANIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CHINESE HAMSTER; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIMERIZATION; DISULFIDE BOND; EMBRYO; EXAMINATION; EXTRACELLULAR SPACE; GENE MUTATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MOUSE; MUTAGENESIS; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; ANTIGENS, CD; BINDING SITES; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; DIMERIZATION; HUMANS; KIDNEY; MICE; MOLECULAR CONFORMATION; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; MUTAGENESIS, SITE-DIRECTED; NIH 3T3 CELLS; PROTEIN BINDING; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL ENVELOPE PROTEINS;

HEPATITIS C VIRUS;

EID: 12844284635     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.12.160     Document Type: Article

References (19)

1. K. Kitadokoro, D. Bordo, G. Galli, R. Petracca, F. Falugi, S. Abrignani, G. Grandi, and M. Bolognesi CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs EMBO J. 20 2001 12 18
2. B. Bartosch, A. Vitelli, C. Granier, C. Goujon, J. Dubuisson, S. Pascale, E. Scarselli, R. Cortese, A. Nicosia, and F.L. Cosset Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor J. Biol. Chem. 278 2003 41624 41630
3. J. Zhang, G. Randall, A. Higginbottom, P. Monk, C.M. Rice, and J.A. McKeating CD81 is required for hepatitis C virus glycoprotein-mediated viral infection J. Virol. 78 2004 1448 1455
4. A. Wack, E. Soldaini, C. Tseng, S. Nuti, G. Klimpel, S. Abrignani, C. Agrati, C. Nisii, A. Oliva, G. D'Offizi, C. Montesano, L.P. Pucillo, and F. Poccia Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells Eur. J. Immunol. 31 2001 166 175
5. C.T. Tseng, and G.R. Klimpel Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions J. Exp. Med. 195 2002 43 49
6. S. Crotta, A. Stilla, A. Wack, A. D'Andrea, S. Nuti, U. D'Oro, M. Mosca, F. Filliponi, R.M. Brunetto, F. Bonino, S. Abrignani, and N.M. Valiante Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein J. Exp. Med. 195 2002 35 41
7. H.E. Drummer, K.A. Wilson, and P. Poumbourios Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81 J. Virol. 76 2002 11143 11147
8. M. Wilm, G. Neubauer, and M. Mann Parent ion scans of unseparated peptide mixtures Anal. Chem. 68 1996 527 533
9. R.J. Center, B. Kobe, K.A. Wilson, T. Teh, G.J. Howlett, B.E. Kemp, and P. Poumbourios Crystallization of a trimeric human T cell leukemia virus type 1 gp21 ectodomain fragment as a chimera with maltose-binding protein Protein Sci. 7 1998 1612 1619
10. Y.H. Abacioglu, T.R. Fouts, J.D. Laman, E. Claassen, S.H. Pincus, J.P. Moore, C.A. Roby, R. Kamin-Lewis, G.K. Lewis, G. Galli, R. Petracca, F. Falugi, S. Abrignani, G. Grandi, and M. Bolognesi Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies AIDS Res. Hum. Retroviruses 10 1994 371 381
11. F.C. Greenwood, W.M. Hunter, and J.S. Glover The preparation of I-131-labelled human growth hormone of high specific radioactivity Biochem. J. 89 1963 114 123
12. K.A. Wilson, A.L. Maerz, and P. Poumbourios Evidence that the transmembrane domain proximal region of the human T-cell leukemia virus type 1 fusion glycoprotein gp21 has distinct roles in the perfusion and fusion-activated states J. Biol. Chem. 276 2001 49466 49475
13. R. Oren, S. Takahashi, C. Doss, R. Levy, and S. Levy TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins Mol. Cell. Biol. 10 1990 4007 4015
14. J.L. Lin-Goerke, D.J. Robbins, and J.D. Burczak PCR-based random mutagenesis using manganese and reduced dNTP concentration Biotechniques 23 1997 409 412
15. P. Poumbourios, D.A. McPhee, and B.E. Kemp Antibody epitopes sensitive to the state of human immunodeficiency virus type 1 gp41 oligomerization map to a putative alpha-helical region AIDS Res. Hum. Retroviruses 8 1992 2055 2062
16. S. Charrin, F. Le Naour, M. Oualid, M. Billard, G. Faure, S.M. Hanash, C. Boucheix, and E. Rubinstein The major CD9 and CD81 molecular partner. Identification and characterization of the complexes J. Biol. Chem. 276 2001 14329 14337
17. O.V. Kovalenko, X. Yang, T.V. Kolesnikova, and M.E. Hemler Evidence for specific tetraspanin homodimers: inhibition of palmitoylation makes cysteine residues available for cross-linking Biochem. J. 377 2004 407 417
18. K.S. Cannon, and P. Cresswell Quality control of transmembrane domain assembly in the tetraspanin CD82 EMBO J. 20 2001 2443 2453
19. F. Masciopinto, S. Campagnoli, S. Abrignani, Y. Uematsu, and P. Pileri The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor Virus Res. 80 2001 1 10